Gran dies after 'sudden and severe pain' when increasing dose of Mounjaro

Daily MailIndependentCenter5 hr. ago

Caroline Savage, a 73-year-old grandmother, died after experiencing severe abdominal pain following an increased dosage of the weight loss drug Mounjaro. The inquest revealed that she had been using the drug privately for several months under the guidance of her doctor, who advised her to increase the dose. After being evaluated at Norfolk and Norwich Hospital and subsequently discharged, she collapsed at home and passed away later that night. The cause of death was determined to be faecal peritonitis due to intestinal perforation. While the hospital acknowledged suboptimal record-keeping, they maintained that appropriate medical procedures were followed. The family expressed concerns that the doctors may have prematurely attributed her symptoms to the drug rather than conducting further investigations.

Bias read (Center): The article presents a factual account of the incident without evident ideological framing. It includes perspectives from both the family and the hospital representatives, providing a balanced view of the situation without showing clear bias toward either side.

Daily MirrorIndependentProgressive6 hr. ago

Caroline Savage, a 73-year-old woman from Norfolk, died after experiencing 'sudden and severe pain' attributed to a tear in her intestines. An inquest is investigating whether her death is linked to increasing the dose of her Mounjaro, a weight-loss medication known for gastrointestinal side effects. The inquest heard that Mrs. Savage had been advised to increase her dosage on a private prescription, leading to her condition. Her family argues that medical professionals may have prematurely dismissed her symptoms as side effects rather than pursuing further investigation. Mrs. Savage had struggled with weight loss through diet and exercise, weighing 128kg (20st) in July 2024. Despite warnings about potential side effects, she continued treatment until she developed severe abdominal pain on October 18, 2024. Emergency services were called, but due to hospital overcrowding, she remained in an ambulance. Medical assessments initially considered pancreatitis as a possibility, but tests ruled it out. Doctors ultimately decided against admitting her or conducting further imaging, citing recognized side effects as sufficient for a diagnosis.

Bias read (Progressive): The article frames the incident as a potential failure of medical oversight and highlights concerns about the safety profile of weight-loss medications like Mounjaro. While the focus is on medical decision-making, the narrative leans toward questioning pharmaceutical companies and healthcare systems